{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:22:07Z","timestamp":1707524527549},"reference-count":77,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,13]]},"DOI":"10.7759\/cureus.21224","type":"journal-article","created":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T06:57:06Z","timestamp":1642143426000},"source":"Crossref","is-referenced-by-count":0,"title":["Chronic Heart Failure: Clinical Implications of Iron Homeostasis Disturbances Revisited"],"prefix":"10.7759","author":[{"given":"Leonardo P","family":"Suciadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Henrina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iwan Cahyo Santosa","family":"Putra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irvan","family":"Cahyadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoo Felicia Hadi","family":"Gunawan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.12005","article-title":"Heart failure: preventing disease and death worldwide","volume":"1","author":"Ponikowski P","year":"2014","unstructured":"Ponikowski P, Anker SD, AlHabib KF, et al.. Heart failure: preventing disease and death worldwide. ESC Heart Fail. 2014, 1:4-25. 10.1002\/ehf2.12005","journal-title":"ESC Heart Fail"},{"key":"ref2","article-title":"Pathophysiology of heart failure","author":"Hasenfuss G","year":"2019","unstructured":"Hasenfuss G, Mann DL. Pathophysiology of heart failure. Braunwald\u2019s Heart Disease: A Textbook of Cardiovascular Medicine. 11th ed. Elsevier, Philadelphia, PA; 2019."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2007.11.061","article-title":"Heart failure incidence and survival (from the Atherosclerosis Risk in Communities study)","volume":"101","author":"Loehr LR","year":"2008","unstructured":"Loehr LR, Rosamond WD, Chang PP, Folsom AR, Chambless LE. Heart failure incidence and survival (from the Atherosclerosis Risk in Communities study). Am J Cardiol. 2008, 101:1016-22. 10.1016\/j.amjcard.2007.11.061","journal-title":"Am J Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski P","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, et al.. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016, 37:2129-200. 10.1093\/eurheartj\/ehw128","journal-title":"Eur Heart J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.104.500546","article-title":"Mechanisms and models in heart failure: the biomechanical model and beyond","volume":"111","author":"Mann DL","year":"2005","unstructured":"Mann DL, Bristow MR. Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation. 2005, 111:2837-49. 10.1161\/CIRCULATIONAHA.104.500546","journal-title":"Circulation"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.03.061","article-title":"Sympathetic nervous system activation in human heart failure: clinical implications of an updated model","volume":"54","author":"Floras JS","year":"2009","unstructured":"Floras JS. Sympathetic nervous system activation in human heart failure: clinical implications of an updated model. J Am Coll Cardiol. 2009, 54:375-85. 10.1016\/j.jacc.2009.03.061","journal-title":"J Am Coll Cardiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2003.tb00197.x","article-title":"Heart failure: a hemodynamic disorder complicated by maladaptive proliferative responses","volume":"7","author":"Katz AM","year":"2003","unstructured":"Katz AM. Heart failure: a hemodynamic disorder complicated by maladaptive proliferative responses. J Cell Mol Med. 2003, 7:1-10. 10.1111\/j.1582-4934.2003.tb00197.x","journal-title":"J Cell Mol Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2014-305669","article-title":"Iron deficiency: an emerging therapeutic target in heart failure","volume":"100","author":"Cohen-Solal A","year":"2014","unstructured":"Cohen-Solal A, Leclercq C, Deray G, et al.. Iron deficiency: an emerging therapeutic target in heart failure. Heart. 2014, 100:1414-20. 10.1136\/heartjnl-2014-305669","journal-title":"Heart"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12311","article-title":"Guideline for the laboratory diagnosis of functional iron deficiency","volume":"161","author":"Thomas DW","year":"2013","unstructured":"Thomas DW, Hinchliffe RF, Briggs C, Macdougall IC, Littlewood T, Cavill I. Guideline for the laboratory diagnosis of functional iron deficiency. Br J Haematol. 2013, 161:639-48. 10.1111\/bjh.12311","journal-title":"Br J Haematol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy CW","year":"2013","unstructured":"Yancy CW, Jessup M, Bozkurt B, et al.. 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013, 62:e147-239. 10.1016\/j.jacc.2013.05.019","journal-title":"J Am Coll Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs224","article-title":"Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives","volume":"34","author":"Jankowska EA","year":"2013","unstructured":"Jankowska EA, von Haehling S, Anker SD, Macdougall IC, Ponikowski P. Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives. Eur Heart J. 2013, 34:816-29. 10.1093\/eurheartj\/ehs224","journal-title":"Eur Heart J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2013.01.017","article-title":"Iron deficiency in chronic heart failure: an international pooled analysis","volume":"165","author":"Klip IT","year":"2013","unstructured":"Klip IT, Comin-Colet J, Voors AA, et al.. Iron deficiency in chronic heart failure: an international pooled analysis. Am Heart J. 2013, 165:575-582.e3. 10.1016\/j.ahj.2013.01.017","journal-title":"Am Heart J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra063052","article-title":"The failing heart \u2014 an engine out of fuel","volume":"356","author":"Neubauer S","year":"2007","unstructured":"Neubauer S. The failing heart \u2014 an engine out of fuel. N Engl J Med. 2007, 356:1140-51. 10.1056\/NEJMra063052","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1113\/expphysiol.2012.064709","article-title":"Investigating cardiac energetics in heart failure","volume":"98","author":"Lygate CA","year":"2013","unstructured":"Lygate CA, Schneider JE, Neubauer S. Investigating cardiac energetics in heart failure. Exp Physiol. 2013, 98:601-5. 10.1113\/expphysiol.2012.064709","journal-title":"Exp Physiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1631\/jzus.B1300137","article-title":"Metabolic remodeling in chronic heart failure","volume":"14","author":"Wang J","year":"2013","unstructured":"Wang J, Guo T. Metabolic remodeling in chronic heart failure. J Zhejiang Univ Sci B. 2013, 14:688-95. 10.1631\/jzus.B1300137","journal-title":"J Zhejiang Univ Sci B"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hfr173","article-title":"Targeting myocardial substrate metabolism in heart failure: potential for new therapies","volume":"14","author":"Ardehali H","year":"2012","unstructured":"Ardehali H, Sabbah HN, Burke MA, et al.. Targeting myocardial substrate metabolism in heart failure: potential for new therapies. Eur J Heart Fail. 2012, 14:120-9. 10.1093\/eurjhf\/hfr173","journal-title":"Eur J Heart Fail"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-7133.2011.00255.x","article-title":"Mitochondrial dynamics in heart failure","volume":"17","author":"Chen L","year":"2011","unstructured":"Chen L, Knowlton AA. Mitochondrial dynamics in heart failure. Congest Heart Fail. 2011, 17:257-61. 10.1111\/j.1751-7133.2011.00255.x","journal-title":"Congest Heart Fail"},{"key":"ref18","article-title":"The cytoskeleton of the cardiac muscle cell","volume":"53","author":"Sarantitis I","year":"2012","unstructured":"Sarantitis I, Papanastasopoulos P, Manousi M, Baikoussis NG, Apostolakis E. The cytoskeleton of the cardiac muscle cell. Hellenic J Cardiol. 2012, 53:367-79.","journal-title":"Hellenic J Cardiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.08.1021","article-title":"Mitochondria as a therapeutic target in heart failure","volume":"61","author":"Bayeva M","year":"2013","unstructured":"Bayeva M, Gheorghiade M, Ardehali H. Mitochondria as a therapeutic target in heart failure. J Am Coll Cardiol. 2013, 61:599-610. 10.1016\/j.jacc.2012.08.1021","journal-title":"J Am Coll Cardiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2016.1268047","article-title":"Mitochondria and iron: current questions","volume":"10","author":"Paul BT","year":"2017","unstructured":"Paul BT, Manz DH, Torti FM, Torti SV. Mitochondria and iron: current questions. Expert Rev Hematol. 2017, 10:65-79. 10.1080\/17474086.2016.1268047","journal-title":"Expert Rev Hematol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2012.5014","article-title":"Iron and reactive oxygen species: friends or foes of cancer cells?","volume":"20","author":"Bystrom LM","year":"2014","unstructured":"Bystrom LM, Guzman ML, Rivella S. Iron and reactive oxygen species: friends or foes of cancer cells?. Antioxid Redox Signal. 2014, 20:1917-24. 10.1089\/ars.2012.5014","journal-title":"Antioxid Redox Signal"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2011.1.532","article-title":"Unraveling mechanisms regulating systemic iron homeostasis","volume":"2011","author":"Finberg KE","year":"2011","unstructured":"Finberg KE. Unraveling mechanisms regulating systemic iron homeostasis. Hematology Am Soc Hematol Educ Program. 2011, 2011:532-7. 10.1182\/asheducation-2011.1.532","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1159\/000362888","article-title":"Physiology of iron metabolism","volume":"41","author":"Waldvogel-Abramowski S","year":"2014","unstructured":"Waldvogel-Abramowski S, Waeber G, Gassner C, Buser A, Frey BM, Favrat B, Tissot JD. Physiology of iron metabolism. Transfus Med Hemother. 2014, 41:213-21. 10.1159\/000362888","journal-title":"Transfus Med Hemother"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-008-0120-5","article-title":"Body iron metabolism and pathophysiology of iron overload","volume":"88","author":"Kohgo Y","year":"2008","unstructured":"Kohgo Y, Ikuta K, Ohtake T, Torimoto Y, Kato J. Body iron metabolism and pathophysiology of iron overload. Int J Hematol. 2008, 88:7-15. 10.1007\/s12185-008-0120-5","journal-title":"Int J Hematol"},{"key":"ref25","article-title":"Normal iron metabolism and the pathophysiology of iron overload disorders","volume":"27","author":"Siah CW","year":"2006","unstructured":"Siah CW, Ombiga J, Adams LA, Trinder D, Olynyk JK. Normal iron metabolism and the pathophysiology of iron overload disorders. Clin Biochem Rev. 2006, 27:5-16.","journal-title":"Clin Biochem Rev"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/nu9121327","article-title":"Iron supplementation during pregnancy and infancy: uncertainties and implications for research and policy","volume":"9","author":"Brannon PM","year":"2017","unstructured":"Brannon PM, Taylor CL. Iron supplementation during pregnancy and infancy: uncertainties and implications for research and policy. Nutrients. 2017, 9:1327. 10.3390\/nu9121327","journal-title":"Nutrients"},{"key":"ref27","article-title":"Iron transport & homeostasis mechanisms: their role in health & disease","volume":"128","author":"Nadadur SS","year":"2008","unstructured":"Nadadur SS, Srirama K, Mudipalli A. Iron transport & homeostasis mechanisms: their role in health & disease. Indian J Med Res. 2008, 128:533-44.","journal-title":"Indian J Med Res"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20150014","article-title":"Hepcidin: regulation of the master iron regulator","volume":"35","author":"Rishi G","year":"2015","unstructured":"Rishi G, Wallace DF, Subramaniam VN. Hepcidin: regulation of the master iron regulator. Biosci Rep. 2015, 35:251-54. 10.1042\/BSR20150014","journal-title":"Biosci Rep"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1097\/00062752-200407000-00004","article-title":"Hepcidin in iron metabolism","volume":"11","author":"Ganz T","year":"2004","unstructured":"Ganz T. Hepcidin in iron metabolism. Curr Opin Hematol. 2004, 11:251-4. 10.1097\/00062752-200407000-00004","journal-title":"Curr Opin Hematol"},{"key":"ref30","article-title":"Review on iron and its importance for human health","volume":"19","author":"Abbaspour N","year":"2014","unstructured":"Abbaspour N, Hurrell R, Kelishadi R. Review on iron and its importance for human health. J Res Med Sci. 2014, 19:164-74.","journal-title":"J Res Med Sci"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a011668","article-title":"Iron metabolism: interactions with normal and disordered erythropoiesis","volume":"2","author":"Ganz T","year":"2012","unstructured":"Ganz T, Nemeth E. Iron metabolism: interactions with normal and disordered erythropoiesis. Cold Spring Harb Perspect Med. 2012, 2:a011668. 10.1101\/cshperspect.a011668","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3390\/nu5093730","article-title":"Iron deficiency in heart failure: a practical guide","volume":"5","author":"Ebner N","year":"2013","unstructured":"Ebner N, von Haehling S. Iron deficiency in heart failure: a practical guide. Nutrients. 2013, 5:3730-9. 10.3390\/nu5093730","journal-title":"Nutrients"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.2174\/092986705774462969","article-title":"Structure\/function overview of proteins involved in iron storage and transport","volume":"12","author":"Sargent PJ","year":"2005","unstructured":"Sargent PJ, Farnaud S, Evans RW. Structure\/function overview of proteins involved in iron storage and transport. Curr Med Chem. 2005, 12:2683-93. 10.2174\/092986705774462969","journal-title":"Curr Med Chem"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21886","article-title":"Hemochromatosis: an endocrine liver disease","volume":"46","author":"Pietrangelo A","year":"2007","unstructured":"Pietrangelo A. Hemochromatosis: an endocrine liver disease. Hepatology. 2007, 46:1291-301. 10.1002\/hep.21886","journal-title":"Hepatology"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1242\/jeb.043075","article-title":"Myoglobin's old and new clothes: from molecular structure to function in living cells","volume":"213","author":"Gros G","year":"2010","unstructured":"Gros G, Wittenberg BA, Jue T. Myoglobin's old and new clothes: from molecular structure to function in living cells. J Exp Biol. 2010, 213:2713-25. 10.1242\/jeb.043075","journal-title":"J Exp Biol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/s1050-1738(02)00256-6","article-title":"Emerging roles for myoglobin in the heart","volume":"13","author":"Garry DJ","year":"2003","unstructured":"Garry DJ, Kanatous SB, Mammen PPA. Emerging roles for myoglobin in the heart. Trends Cardiovasc Med. 2003, 13:111-6. 10.1016\/s1050-1738(02)00256-6","journal-title":"Trends Cardiovasc Med"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1242\/jeb.01172","article-title":"Myoglobin: an essential hemoprotein in striated muscle","volume":"207","author":"Ordway GA","year":"2004","unstructured":"Ordway GA, Garry DJ. Myoglobin: an essential hemoprotein in striated muscle. J Exp Biol. 2004, 207:3441-6. 10.1242\/jeb.01172","journal-title":"J Exp Biol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1242\/jeb.003947","article-title":"Myoglobin-enhanced oxygen delivery to isolated cardiac mitochondria","volume":"210","author":"Wittenberg JB","year":"2007","unstructured":"Wittenberg JB, Wittenberg BA. Myoglobin-enhanced oxygen delivery to isolated cardiac mitochondria. J Exp Biol. 2007, 210:2082-90. 10.1242\/jeb.003947","journal-title":"J Exp Biol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1096\/fj.03-1382fje","article-title":"Role of myoglobin in the antioxidant defense of the heart","volume":"18","author":"Fl\u00f6gel U","year":"2004","unstructured":"Fl\u00f6gel U, G\u00f6decke A, Klotz LO, Schrader J. Role of myoglobin in the antioxidant defense of the heart. FASEB J. 2004, 18:1156-8. 10.1096\/fj.03-1382fje","journal-title":"FASEB J"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.98.2.735","article-title":"Myoglobin: a scavenger of bioactive NO","volume":"16","author":"Fl\u00f6gel U","year":"2001","unstructured":"Fl\u00f6gel U, Merx MW, G\u00f6decke A, Decking UKM, Schrader J. Myoglobin: a scavenger of bioactive NO. Proc Natl Acad Sci. 2001, 16:735-40. 10.1073\/pnas.98.2.735","journal-title":"Proc Natl Acad Sci"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00147.2003","article-title":"Hypoxia-induced left ventricular dysfunction in myoglobin-deficient mice","volume":"285","author":"Mammen PP","year":"2003","unstructured":"Mammen PP, Kanatous SB, Yuhanna IS, Shaul PW, Garry MG, Balaban RS, Garry DJ. Hypoxia-induced left ventricular dysfunction in myoglobin-deficient mice. Am J Physiol Heart Circ Physiol. 2003, 285:H2132-41. 10.1152\/ajpheart.00147.2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1159\/000452104","article-title":"Anaemia of chronic disease: an in-depth review","volume":"26","author":"Madu AJ","year":"2017","unstructured":"Madu AJ, Ughasoro MD. Anaemia of chronic disease: an in-depth review. Med Princ Pract. 2017, 26:1-9. 10.1159\/000452104","journal-title":"Med Princ Pract"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.04.040","article-title":"Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival","volume":"58","author":"Okonko DO","year":"2011","unstructured":"Okonko DO, Mandal AK, Missouris CG, Poole-Wilson PA. Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival. J Am Coll Cardiol. 2011, 58:1241-51. 10.1016\/j.jacc.2011.04.040","journal-title":"J Am Coll Cardiol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2008.08.006","article-title":"Iron metabolism in the anemia of chronic disease","volume":"1790","author":"Weiss G","year":"2009","unstructured":"Weiss G. Iron metabolism in the anemia of chronic disease. Biochim Biophys Acta. 2009, 1790:682-93. 10.1016\/j.bbagen.2008.08.006","journal-title":"Biochim Biophys Acta"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.08.034","article-title":"Etiology of anemia in patients with advanced heart failure","volume":"48","author":"Nanas JN","year":"2006","unstructured":"Nanas JN, Matsouka C, Karageorgopoulos D, et al.. Etiology of anemia in patients with advanced heart failure. J Am Coll Cardiol. 2006, 48:2485-9. 10.1016\/j.jacc.2006.08.034","journal-title":"J Am Coll Cardiol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.01.059","article-title":"Myocardial and systemic iron depletion in heart failure implications for anemia accompanying heart failure","volume":"58","author":"Maeder MT","year":"2011","unstructured":"Maeder MT, Khammy O, dos Remedios C, Kaye DM. Myocardial and systemic iron depletion in heart failure implications for anemia accompanying heart failure. J Am Coll Cardiol. 2011, 58:474-80. 10.1016\/j.jacc.2011.01.059","journal-title":"J Am Coll Cardiol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00463.2008","article-title":"Adaptive response of the heart to long-term anemia induced by iron deficiency","volume":"296","author":"Naito Y","year":"2009","unstructured":"Naito Y, Tsujino T, Matsumoto M, Sakoda T, Ohyanagi M, Masuyama T. Adaptive response of the heart to long-term anemia induced by iron deficiency. Am J Physiol Heart Circ Physiol. 2009, 296:H585-93. 10.1152\/ajpheart.00463.2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq158","article-title":"Iron deficiency: an ominous sign in patients with systolic chronic heart failure","volume":"31","author":"Jankowska EA","year":"2010","unstructured":"Jankowska EA, Rozentryt P, Witkowska A, et al.. Iron deficiency: an ominous sign in patients with systolic chronic heart failure. Eur Heart J. 2010, 31:1872-80. 10.1093\/eurheartj\/ehq158","journal-title":"Eur Heart J"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.1529","article-title":"Iron deficiency without anemia - a clinical challenge","volume":"6","author":"Soppi ET","year":"2018","unstructured":"Soppi ET. Iron deficiency without anemia - a clinical challenge. Clin Case Rep. 2018, 6:1082-6. 10.1002\/ccr3.1529","journal-title":"Clin Case Rep"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2006.01.107","article-title":"Anemia, renal dysfunction, and their interaction in patients with chronic heart failure","volume":"98","author":"de Silva R","year":"2006","unstructured":"de Silva R, Rigby AS, Witte KK, et al.. Anemia, renal dysfunction, and their interaction in patients with chronic heart failure. Am J Cardiol. 2006, 98:391-8. 10.1016\/j.amjcard.2006.01.107","journal-title":"Am J Cardiol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1042\/CS20040278","article-title":"Dietary iron deficiency induces ventricular dilation, mitochondrial ultrastructural aberrations and cytochrome c release: involvement of nitric oxide synthase and protein tyrosine nitration","volume":"109","author":"Dong F","year":"2005","unstructured":"Dong F, Zhang X, Culver B, Chew HG Jr, Kelley RO, Ren J. Dietary iron deficiency induces ventricular dilation, mitochondrial ultrastructural aberrations and cytochrome c release: involvement of nitric oxide synthase and protein tyrosine nitration. Clin Sci (Lond). 2005, 109:277-86. 10.1042\/CS20040278","journal-title":"Clin Sci (Lond)"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.nutr.23.020102.075739","article-title":"Iron status and neural functioning","volume":"23","author":"Beard JL","year":"2003","unstructured":"Beard JL, Connor JR. Iron status and neural functioning. Annu Rev Nutr. 2003, 23:41-58. 10.1146\/annurev.nutr.23.020102.075739","journal-title":"Annu Rev Nutr"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.07.029","article-title":"Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency","volume":"50","author":"Toblli JE","year":"2007","unstructured":"Toblli JE, Lombra\u00f1a A, Duarte P, Di Gennaro F. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. J Am Coll Cardiol. 2007, 50:1657-65. 10.1016\/j.jacc.2007.07.029","journal-title":"J Am Coll Cardiol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker SD","year":"2009","unstructured":"Anker SD, Comin Colet J, Filippatos G, et al.. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med. 2009, 361:2436-48. 10.1056\/NEJMoa0908355","journal-title":"N Engl J Med"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2013.04.181","article-title":"IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia","volume":"168","author":"Beck-da-Silva L","year":"2013","unstructured":"Beck-da-Silva L, Piardi D, Soder S, et al.. IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia. Int J Cardiol. 2013, 168:3439-42. 10.1016\/j.ijcard.2013.04.181","journal-title":"Int J Cardiol"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu385","article-title":"Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency","volume":"36","author":"Ponikowski P","year":"2015","unstructured":"Ponikowski P, van Veldhuisen DJ, Comin-Colet J, et al.. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency. Eur Heart J. 2015, 36:657-68. 10.1093\/eurheartj\/ehu385","journal-title":"Eur Heart J"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlc.2014.12.161","article-title":"Changes in echocardiographic parameters in iron deficiency patients with heart failure and chronic kidney disease treated with intravenous iron","volume":"24","author":"Toblli JE","year":"2015","unstructured":"Toblli JE, Di Gennaro F, Rivas C. Changes in echocardiographic parameters in iron deficiency patients with heart failure and chronic kidney disease treated with intravenous iron. Heart Lung Circ. 2015, 24:686-95. 10.1016\/j.hlc.2014.12.161","journal-title":"Heart Lung Circ"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.027497","article-title":"Effect of ferric carboxymaltose on exercise capacity in patients with chronic heart failure and iron deficiency","volume":"136","author":"van Veldhuisen DJ","year":"2017","unstructured":"van Veldhuisen DJ, Ponikowski P, van der Meer P, et al.. Effect of ferric carboxymaltose on exercise capacity in patients with chronic heart failure and iron deficiency. Circulation. 2017, 136:1374-83. 10.1161\/CIRCULATIONAHA.117.027497","journal-title":"Circulation"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.04.025","article-title":"2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the\u00a0management of heart failure: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America","volume":"70","author":"Yancy CW","year":"2017","unstructured":"Yancy CW, Jessup M, Bozkurt B, et al.. 2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the\u00a0management of heart failure: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Am Coll Cardiol. 2017, 70:776-803. 10.1016\/j.jacc.2017.04.025","journal-title":"J Am Coll Cardiol"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21154","article-title":"Intravenous iron: from anathema to standard of care","volume":"83","author":"Auerbach M","year":"2008","unstructured":"Auerbach M, Coyne D, Ballard H. Intravenous iron: from anathema to standard of care. Am J Hematol. 2008, 83:580-8. 10.1002\/ajh.21154","journal-title":"Am J Hematol"},{"key":"ref61","article-title":"Intravenous iron-dextran: therapeutic and experimental possibilities [Article in German]","volume":"100","author":"Ganzoni AM","year":"1970","unstructured":"Ganzoni AM. Intravenous iron-dextran: therapeutic and experimental possibilities [Article in German]. Schweiz Med Wochenschr. 1970, 100:301-3.","journal-title":"Schweiz Med Wochenschr"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.5427","article-title":"Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency. The IRONOUT HF Randomized Clinical Trial","volume":"317","author":"Lewis GD","year":"2017","unstructured":"Lewis GD, Malhotra R, Hernandez AF, et al.. Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency. The IRONOUT HF Randomized Clinical Trial. JAMA. 2017, 317:1958-66. 10.1001\/jama.2017.5427","journal-title":"JAMA"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.2459\/JCM.0000000000000736","article-title":"Identifying responders to oral iron supplementation in heart failure with a reduced ejection fraction: a post-hoc analysis of the IRONOUT-HF trial","volume":"20","author":"Ambrosy AP","year":"2019","unstructured":"Ambrosy AP, Lewis GD, Malhotra R, et al.. Identifying responders to oral iron supplementation in heart failure with a reduced ejection fraction: a post-hoc analysis of the IRONOUT-HF trial. J Cardiovasc Med (Hagerstown). 2019, 20:223-5. 10.2459\/JCM.0000000000000736","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.12250","article-title":"Single-dose intravenous iron in Southeast Asian heart failure patients: a pilot randomized placebo-controlled study (PRACTICE-ASIA-HF)","volume":"5","author":"Yeo TJ","year":"2018","unstructured":"Yeo TJ, Yeo PS, Hadi FA, et al.. Single-dose intravenous iron in Southeast Asian heart failure patients: a pilot randomized placebo-controlled study (PRACTICE-ASIA-HF). ESC Heart Fail. 2018, 5:344-53. 10.1002\/ehf2.12250","journal-title":"ESC Heart Fail"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.038516","article-title":"Effect of iron isomaltoside on skeletal muscle energetics in patients with chronic heart failure and iron deficiency","volume":"139","author":"Charles-Edwards G","year":"2019","unstructured":"Charles-Edwards G, Amaral N, Sleigh A, et al.. Effect of iron isomaltoside on skeletal muscle energetics in patients with chronic heart failure and iron deficiency. Circulation. 2019, 139:2386-98. 10.1161\/CIRCULATIONAHA.118.038516","journal-title":"Circulation"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.014254","article-title":"Noninvasive imaging estimation of myocardial iron repletion following administration of intravenous iron: the Myocardial-IRON Trial","volume":"9","author":"N\u00fa\u00f1ez J","year":"2020","unstructured":"N\u00fa\u00f1ez J, Mi\u00f1ana G, Cardells I, et al.. Noninvasive imaging estimation of myocardial iron repletion following administration of intravenous iron: the Myocardial-IRON Trial. J Am Heart Assoc. 2020, 9:e014254. 10.1161\/JAHA.119.014254","journal-title":"J Am Heart Assoc"},{"key":"ref67","unstructured":"Intravenous iron in patients with systolic heart failure and iron deficiency to improve morbidity & mortality. (2021). Accessed. July 9, 2021: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03036462."},{"key":"ref68","unstructured":"Randomized placebo-controlled trial of FCM as treatment for heart failure with iron deficiency. (2021). Accessed. July 9, 2021: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03037931."},{"key":"ref69","unstructured":"Study to compare ferric carboxymaltose with placebo in patients with acute heart failure and iron deficiency. (2021). Accessed. July 9, 2021: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02937454."},{"key":"ref70","unstructured":"Effect of IV iron in patients with heart failure with preserved ejection fraction. (2020). Accessed. July 9, 2021: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03074591."},{"key":"ref71","unstructured":"Effects of iron therapy in heart failure with preserved ejection fraction and iron deficiency (PREFER-HF). (2019). Accessed. July 9, 2021: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03833336."},{"key":"ref72","unstructured":"Ferric carboxymaltose to improve skeletal muscle metabolism in heart failure patients with functional iron deficiency. (2021). Accessed. July 9, 2021: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03218384."},{"key":"ref73","unstructured":"Effects of iron therapy and exercise training in patients with heart failure and iron deficiency. (2021). Accessed. July 9, 2021: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03803111."},{"key":"ref74","unstructured":"Iron deficiency in heart failure patients. (2019). Accessed. July 7, 2020: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03883854."},{"key":"ref75","unstructured":"Study of the prevalence of iron deficiency in patients with heart failure (CARENFER IC). (2019). Accessed. July 7, 2020: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03924258."},{"key":"ref76","unstructured":"IV iron in acute decompensated heart failure. (2019). Accessed. July 7, 2020: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04063033."},{"key":"ref77","unstructured":"Iron in patients with cardiovascular disease (iCHF-2). (2019). Accessed. July 7, 2020: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03991000."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/70994-chronic-heart-failure-clinical-implications-of-iron-homeostasis-disturbances-revisited","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:41:34Z","timestamp":1707507694000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/70994-chronic-heart-failure-clinical-implications-of-iron-homeostasis-disturbances-revisited"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,13]]},"references-count":77,"URL":"https:\/\/doi.org\/10.7759\/cureus.21224","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,13]]}}}